Spire Wealth Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Spire Wealth Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-867	Closed	-$5K	–	2990
2021 Q4	$5K	Buy	+867	New	+$7.37K	﹤0.01%	2593
2021 Q2	–	Sell	-667	Closed	-$19K	–	3088
2021 Q1	$19K	Buy	+667	New	+$30.3K	﹤0.01%	2179

Other funds holding EVFM

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spire Wealth Management's EVFM Position: Q1 2022 in Review

Spire Wealth Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2022, closing a stake of 867 shares — an estimated $5K sold.

Spire Wealth Management first reported a position in EVFM in Q1 2021 and held it in 2 quarters. The position peaked at $19K in Q1 2021. 68 funds tracked by Wall St. Rank hold EVFM as of Q1 2022.

Spire Wealth Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Spire Wealth Management sold 867 Evofem Biosciences, Inc. Common Stock shares in Q1 2022, an estimated $5K.
Spire Wealth Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Spire Wealth Management's Evofem Biosciences, Inc. Common Stock position peaked at $19K in Q1 2021.
68 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2022.

Based on Spire Wealth Management's 13F filing for Q1 2022, filed 18 Apr 2022.